Analysts Issue Forecasts for Organigram Q1 Earnings

Organigram Holdings Inc. (TSE:OGI) – Equities researchers at Atb Cap Markets issued their Q1 2025 earnings per share (EPS) estimates for shares of Organigram in a report released on Wednesday, December 18th. Atb Cap Markets analyst F. Gomes anticipates that the company will post earnings of ($0.03) per share for the quarter. The consensus estimate for Organigram’s current full-year earnings is $0.16 per share. Atb Cap Markets also issued estimates for Organigram’s Q2 2025 earnings at ($0.04) EPS, Q3 2025 earnings at ($0.02) EPS and FY2025 earnings at ($0.10) EPS.

OGI has been the topic of a number of other research reports. Canaccord Genuity Group decreased their price objective on Organigram from C$3.60 to C$3.15 and set a “speculative buy” rating on the stock in a research note on Monday, December 9th. ATB Capital decreased their price target on shares of Organigram from C$5.25 to C$3.50 in a research note on Tuesday, December 17th.

Organigram Price Performance

Shares of TSE:OGI opened at C$2.25 on Monday. The company has a debt-to-equity ratio of 1.13, a quick ratio of 2.62 and a current ratio of 6.95. The business’s fifty day moving average price is C$2.26 and its two-hundred day moving average price is C$2.30. The stock has a market cap of C$244.28 million, a PE ratio of -0.90, a price-to-earnings-growth ratio of 0.42 and a beta of 1.13. Organigram has a one year low of C$1.67 and a one year high of C$3.95.

Insider Activity at Organigram

In other Organigram news, Senior Officer Paolo De Luca sold 12,014 shares of the stock in a transaction that occurred on Thursday, October 24th. The shares were sold at an average price of C$2.52, for a total transaction of C$30,275.28. Insiders own 31.32% of the company’s stock.

Organigram Company Profile

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED’ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.